Join
Live feed
·
INSIDERFilingvia Quantisnow
ImmunityBio Inc. logo

SEC Form 4: Sachs David C. converted options into 70,744 shares, increasing direct ownership by 138% to 122,042 units

ByQuantisnow·Wall Street's wire, on your screen.
IBRX· ImmunityBio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IBRX (ImmunityBio Inc.) and more on Quantisnow.